lifestyle.thedishh.com

Author: NovaBridge Biosciences

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update

April 8, 2026
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study

March 9, 2026
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026

March 3, 2026
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference

March 2, 2026
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform

February 19, 2026
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer

February 17, 2026
NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei

January 20, 2026